サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1153809

ラボ情報管理システム（LIMS）の世界市場-2022-2029

Global Laboratory Information Management Systems Market - 2022-2029
出版日: | 発行: DataM Intelligence | ページ情報: 英文 180 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
ラボ情報管理システム（LIMS）の世界市場-2022-2029
出版日: 2022年11月15日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場の概要

ラボ情報管理システム（LIMS）は、ソフトウェアベースのラボおよび情報管理システムであり、現代のラボの運営をサポートする特徴を備えています。柔軟なアーキテクチャ、データ追跡サポート、データ交換インターフェースは、規制された状況下での使用を可能にする必須機能です。これらのシステムは、患者の人口統計、セキュリティ、エンドユーザーへの課金を保証します。また、データのサンプリングや研究資料の統合を促進し、データアクセスをより管理しやすくします。LIMSの用途には、サンプル管理、データマイニング、データ分析、電子ラボネットワークなどがあります。

市場力学

慢性疾患の蔓延、高齢化社会の進展、コンプライアンスや政府規制の遵守、LIMSソフトウェアの技術的進歩、クラウドベースLIMSの採用拡大、製薬会社における研究開発費の増加は、予測期間中の市場成長を促す主要因の一部となっています。

厳しい規制要件を満たすためにLIMSの利用が増加していることが、市場成長の原動力になると予想されます。

製薬会社やバイオテクノロジー企業は、多くの国で新しい治療法を発表する前に、前臨床研究および臨床研究の厳しい規制基準を満たすよう圧力を受けています。例えば、製薬およびバイオテクノロジー業界では、21 CFR Part 11や臨床検査改善法（CLIA）などの規制要件により、研究開発や試験から生産、品質管理までの文書化や監査証跡が義務付けられています。この法律に加えて、認可された表示や広告のガイドラインに従うことが重要です。これらのデータ管理とセキュリティの同意の結果、ほとんどの検査室は、手順を自動化し、厳しい規制基準を満たすためにLIMSを急速に導入しています。これらのシステムは、データを記録し更新するためのラボシステムとの構成が簡単であるため、プロセスの適応性を犠牲にすることなく、規制基準を満たすためにラボを支援します。したがって、対象部門を担当する検査室におけるLIMSのニーズが高まることが予想されます。このように、上記の要因から、予測期間中に市場が牽引されることが予想されます。

一方、熟練した専門家の不足とソフトウェアメンテナンスの高コストが市場成長の妨げになると予想されます。

しかし、ソフトウェアの仕組みを理解し、データや情報の処理・管理中に発生しうる不具合に対処できる熟練した人材が必要です。このような巨額の損失は、市場にとって大きな脅威となります。さらに、LIMSの保守・サービスコストが高いことも、市場の大きな制約要因となっています。ITシステムの保守コストは、製品のコストを上回る。サービスおよびメンテナンスのコストは、変化するユーザーのニーズに合わせてソフトウェアを調整することを含み、繰り返し発生し、総所有コストの約20～30％を占めています。トレーニングや導入のコストは総コストの約15%に相当します。これらの制約により、多くの中小規模の研究所はこれらの技術に投資することが難しく、その導入が制限されています。

COVID-19の影響分析

COVID-19の流行は、ラボ情報管理システム産業にプラスの影響を与えました。パンデミックの間、COVID-19ラボ検査の需要は24時間体制でキャパシティを上回り、ラボの作業員とインフラに大きな負担をかけた。ラボ情報管理システム（LIMS）は、検査室検査のすべての段階（前分析、分析、後分析）を合理化するために使用されています。COVID-19の開発以降、LIMSの利用が拡大し、医療従事者はデータ収集プロセスを効率化することで医療やワクチン研究に集中できるようになっています。さらに、各社はパンデミック時にラボ情報管理システムソフトウェアを開発し、検査室の医師を支援しています。例えば、labWare社は、COVID-19のサーベイランスや結果共有のためのソリューションなど、包括的な機能を提供しています。同社は、フィールドベースおよびCOVID-19検査業務の一環として、COVID-19患者登録およびサンプル採取手順を効率化するためのポータブル・ディジーズ・サーベイランス・ラボ（PDSL）などの技術を生み出しています。これらのソリューションは、同社の顧客である各州の公衆衛生研究所で導入されています。したがって、上記の要因から、予測期間において、市場はプラスの影響を受けます。

目次

第1章 調査手法と調査範囲

  • 調査手法
  • 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場影響要因
    • 促進要因
      • 厳しい規制要件を満たすためにLIMSの利用が増加しており、市場成長の原動力になると予想されます。
    • 抑制要因
      • 熟練した専門家の不足とソフトウェアメンテナンスの高コストが市場成長の妨げになると予想されます。
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターの5つの力
  • サプライチェーン
  • プライシング分析

第6章 COVID-19の分析

  • COVID-19の市場分析
    • COVID-19以前の市場シナリオ
    • COVID-19の現在の市場シナリオ
    • COVID-19の後、または将来のシナリオ
  • COVID-19の中での価格ダイナミクス
  • 需要-供給スペクトラム
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的な取り組み
  • まとめ

第7章 製品タイプ別

  • ソフトウェア
  • サービス

第8章 導入形態別

  • オンプレミス
  • ウェブベース
  • クラウド型

第9章 エンドユーザー別

  • CRO
  • 石油化学精製・石油・ガス業界
  • 化学業界
  • 飲食品・農業関連産業
  • 環境試験所
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A（合併・買収）分析

第12章 企業プロファイル

  • ThermoFisher Scientific, Inc.
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • Siemens Group
  • LabWare
  • PerkinElmer Inc.
  • Abbott Laboratories
  • LabVantage Solutions
  • Novatek International
  • LabLynx Inc.
  • Promium LLC.
  • LABWORKS
  • Illumina, Inc.
  • Autoscribe Informatics

第13章 世界のラボ情報管理システム-DataM

目次
Product Code: DMHCIT546

Market Overview

The global laboratory information management systems size was valued at US$ YY million in 2021 and is expected to reach US$ YY million by 2029, growing at a CAGR of YY% during the forecast period (2022-2029).

LIMS (Laboratory Information Management System) is a software-based laboratory and information management system with characteristics that support a modern laboratory's operations. Flexible architecture, data tracking support, and data interchange interfaces are essential features that allow it to be used in regulated situations. These systems ensure patient demographics, security, and end-user billing. They also boost data sampling and the integration of study material, making data access more manageable. LIMS uses include sample management, data mining, data analysis, and an electronic laboratory network.

Market Dynamics

The growing prevalence of chronic diseases, growing aging population, adherence to compliance and government regulations, technological advancements in the LIMS software, increasing adoption of cloud-based LIMS offerings, and increasing R&D spending in the pharmaceutical companies are some of the major factors driving the growth of the market in the forecasted period.

The increasing use of LIMS to meet stringent regulatory requirements is expected to drive market growth.

Pharmaceutical and biotechnology companies are under pressure to meet stringent regulatory criteria for preclinical and clinical research before releasing new treatments in many countries. For instance, in the pharmaceutical and biotech industries, regulatory requirements such as 21 CFR Part 11 and Clinical Laboratory Improvement Amendments (CLIA) entail documentation and audit trails from research and development and testing to production and quality controls. In addition to this law, it is important to follow the guidelines for authorized labeling and advertising. As a result of these data management and security consent, most laboratories are rapidly embracing LIMS to automate their procedures and meet tight regulatory standards. These systems aid laboratories in satisfying regulatory standards without sacrificing process adaptability since they are straightforward to configure with laboratory systems to record and update data. Therefore, it is expected to enhance the need for LIMS in laboratories serving the target sectors. Thus, from the above-mentioned factors, the market is expected to drive in the forecast period.

The lack of skilled professionals and the high cost of software maintenance is expected to hamper the market growth.

However, it is necessary to have skilled personnel who understand how the software works and can deal with any malfunctions that may occur while processing and managing data and information. Such a massive loss presents a significant threat to the market. Moreover, the high LIMS maintenance and service costs are significant market constraints. IT system maintenance costs exceed the cost of the product. The cost of service and maintenance, which includes adjusting the software to changing user needs, is recurrent and contributes to around 20 to 30% of the total cost of ownership. Training and implementation costs account for around 15% of the total cost. These limitations make it difficult for many small and medium-sized laboratories to invest in these technologies, limiting their adoption.

COVID-19 Impact Analysis

The COVID-19 epidemic positively impacted the laboratory information management systems industry. During the pandemic, demand for COVID -19 laboratory testing surpassed capacity around the clock, putting a major strain on laboratory workers and infrastructure. Laboratory information management systems (LIMS) are being used to streamline all phases of laboratory testing (preanalytical, analytical, and post-analytical). The use of LIMS has increased since the development of COVID-19, allowing healthcare practitioners to focus on medicine and vaccine research by streamlining data collection processes. Moreover, the companies have developed laboratory information management system software during the pandemic to help physicians in the laboratories. For instance, labWare provides a comprehensive set of capabilities, including solutions for COVID-19 surveillance and results sharing. The company is creating technologies, such as the Portable Disease Surveillance Lab (PDSL), to streamline the COVID-19 patient registration and sample collecting procedure as part of field-based and COVID-19 testing operations. These solutions are being implemented at the company's customers' state public health labs. Thus, from the above-mentioned factors, the market is affected positively in the forecast period.

Segment Analysis

Cloud-Based segment is expected to hold the largest market share in laboratory information management systems

The cloud-based segment is accounted for the largest market share in 2021. Cloud-based solutions enable organizations and laboratories to share and integrate data from several locations, resulting in a more efficient data collection procedure. The introduction of cloud-based Internet-enabled services has resulted in significant advancements in the global laboratory information system (LIS) market. Virtualization advancements and improved access to high-speed internet enable faster innovation at reduced costs. Companies that use cloud-based solutions must pay for the software subscription rather than the full licenses.

Furthermore, cloud-based LIS does not necessitate any upfront capital expenditure for hardware, reducing the strain on healthcare and clinical settings while requiring the least amount of IT professionals. Therefore, because of features such as greater data accessibility, cost-effectiveness, and real-time analysis, cloud-based delivery models would emerge as an effective LIS solution with significant growth potential. Thus, from the above-mentioned factors, the market segment accounted for the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global laboratory information management systems

North America region accounted for the largest market share in 2021. Favorable government initiatives, increased investments in R&D by the government, product launches, collaboration and partnership by the market key players are the factors to drive the market in the forecast period. For instance, Ovation, a U.S.-based firm, launched a project in March 2020 centered on its cloud-based LIMS and aimed at enabling independent laboratories to increase their capabilities while effectively tripling testing capacity across the country.

Moreover, McKesson Medical-Surgical collaborated with Orchard Software in February 2022 as an authorized distributor supplying technological solutions that assist laboratory productivity and efficiency. Additionally, in May 2022, LabLynx launched its newest LIS solution, CannaQA Standard Edition, designed for new and expanding cannabis testing labs. This latest LabLynx solution provides a reduced version of the company's enterprise CannaQA solution with all of the product's powerful features but at a lower cost and faster implementation timetable. Thus, from the above-mentioned factors, the North American region accounted for the largest market share in the forecast period.

Competitive Landscape

Major key players in the laboratory information management systems market are: Thermo Fisher Scientific, Inc., Siemens Group, LabWare, PerkinElmer Inc., Abbott Laboratories, LabVantage Solutions, Novatek International, LabLynx Inc., Promium LLC., LABWORKS, Illumina, Inc., Autoscribe Informatics.

On August 31, 2021, CTI Clinical Trial and Consulting Services (CTI) and LabWare, Inc. partnered to provide laboratory services to support rare illnesses and cell and gene therapy research worldwide.

Illumina, Inc.:

Overview:

Illumina, Inc. is an American company that develops, manufactures, and markets integrated systems to analyze genetic variation and biological function. The Company operates through segments such as Core Illumina. Core Illumina's products and services serve customers in the research, clinical and applied markets and enable the adoption of various genomic solutions. The Company's portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Its customers include genomic research centers, academic institutions, government laboratories, hospitals, pharmaceuticals, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies.

Product Portfolio:

Illumina Array LIMS: Illumina offers a state-of-the-art array-based Laboratory Information Management System (LIMS) that guides time-consuming and error-prone sample/data handling and tracking, ensuring reliable, high-quality data outputs and enabling multiple projects to be managed in parallel. The system facilitates high-throughput microarray processing and sample tracking using advanced automation and precise robotic control.

The global laboratory information management systems report would provide an access to an approx. 45+ market data table, 40+ figures and 180 pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The increasing use of LIMS to meet stringent regulatory requirements is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. The lack of skilled professionals and the high cost of software maintenance is expected to hamper the market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces
  • 5.2. Supply Chain
  • 5.3. Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Software*
      • 7.2.1.1. Introduction
      • 7.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Services

8. By Deployment Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Deployment Type
    • 8.1.2. Market Attractiveness Index, By Deployment Type
  • 8.2. On-Premise*
      • 8.2.1.1. Introduction
      • 8.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Web-Based
  • 8.4. Cloud-Based

9. By End user

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 9.1.2. Market Attractiveness Index, By End user
  • 9.2. CROs*
      • 9.2.1.1. Introduction
      • 9.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Petrochemical Refineries & Oil and Gas Industry
  • 9.4. Chemical Industry
  • 9.5. Food and Beverage & Agriculture Industries
  • 9.6. Environmental Testing Laboratories
  • 9.7. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Deployment Type
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Deployment Type
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Deployment Type
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Deployment Type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Deployment Type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. ThermoFisher Scientific, Inc.
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Siemens Group
  • 12.3. LabWare
  • 12.4. PerkinElmer Inc.
  • 12.5. Abbott Laboratories
  • 12.6. LabVantage Solutions
  • 12.7. Novatek International
  • 12.8. LabLynx Inc.
  • 12.9. Promium LLC.
  • 12.10. LABWORKS
  • 12.11. Illumina, Inc.
  • 12.12. Autoscribe Informatics

LIST NOT EXHAUSTIVE

13. Global Laboratory Information Management Systems - DataM

  • 13.1. Appendix
  • 13.2. About Us and Applications
  • 13.3. Contact Us